Throughout this medical market research, the publisher analyzed 44 neurology companies in the United States and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of the US neurological device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes a neurological procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
Neurological Device Market Insights
The neuromodulation devices comprise the largest segment for neurological devices, divided between several competitors in the spinal cord stimulation and deep brain stimulation space. Most other segments, including vagus nerve stimulation, gastric electric stimulation, dorsal root ganglion stimulation and responsive neurostimulation remain monopolized market segments at the time of publication.
With aging demographics and improved early detection, procedure volumes for treating aneurysms are on the rise. Recent clinical trials have demonstrated the greater efficacy of flow-diverting and intrasaccular stents, compared to established techniques.
Overall, the U.S. neuromodulation, neurovascular and neurosurgical device market was valued at $4.8 billion in 2019. This is expected to increase over the forecast period at a CAGR of 6.9% to reach $7.6 billion.
While this MedSuite report contains all of the US neurological device market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes a neurological procedure volume analysis which can also be purchased as a separate report, MedPro.
Markets Covered
- Procedure Volumes for Neurological Devices – MedPro
- Cerebrospinal Fluid Management Market – MedCore
- Detachable Coils Market – MedCore
- Liquid Embolics Market – MedCore
- Neurovascular Catheters Market – MedCore
- Neurovascular Guidewires Market – MedCore
- Neurovascular Stents Market – MedCore
- Balloon Occlusion Market – MedCore
- Aneurysm Clips Market – MedCore
- Neurovascular Thrombus Management Market – MedCore
- Neuromodulation Devices Market – MedCore
- Intrathecal Pumps Market – MedCore
- Stereotactic Surgery Devices Market – MedCore
- Neuroendoscopy Market – MedCore
- Ultrasonic Aspirators Market – MedCore
Neurological Device Market Insights
The neuromodulation devices comprise the largest segment for neurological devices, divided between several competitors in the spinal cord stimulation and deep brain stimulation space. Most other segments, including vagus nerve stimulation, gastric electric stimulation, dorsal root ganglion stimulation and responsive neurostimulation remain monopolized market segments at the time of publication.
With aging demographics and improved early detection, procedure volumes for treating aneurysms are on the rise. Recent clinical trials have demonstrated the greater efficacy of flow-diverting and intrasaccular stents, compared to established techniques.
Overall, the U.S. neuromodulation, neurovascular and neurosurgical device market was valued at $4.8 billion in 2019. This is expected to increase over the forecast period at a CAGR of 6.9% to reach $7.6 billion.
Table of Contents
TABLE OF CONTENTSLIST OF FIGURESLIST OF CHARTS20. ABBREVIATIONS
1. EXECUTIVE SUMMARY
2. DISEASE OVERVIEW
3. U.S. NEUROMODULATION, NEUROVASCULAR AND NEUROSURGICAL DEVICE MARKET OVERVIEW
4. NEUROLOGICAL PROCEDURE NUMBERS
5. CEREBROSPINAL FLUID MANAGEMENT MARKET
6. DETACHABLE COIL MARKET
7. LIQUID EMBOLIC MARKET
8. NEUROVASCULAR CATHETER MARKET
9. NEUROVASCULAR GUIDEWIRE MARKET
10. NEUROVASCULAR STENT MARKET
11. BALLOON OCCLUSION DEVICE MARKET
12. ANEURYSM CLIP MARKET
13. NEUROVASCULAR THROMBUS MANAGEMENT MARKET
14. NEUROMODULATION DEVICE MARKET
15. INTRATHECAL PUMP MARKET
16. STEREOTACTIC MARKET
17. NEUROENDOSCOPY MARKET
18. ULTRASONIC ASPIRATOR MARKET
19. APPENDIX: INTRACEREBRAL HEMORRHAGE TREATMENT
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott
- Accuracy
- Adeor
- Aesculap
- Asahi Intecc
- Axonics
- Balt
- Boston Scientific
- Brainlab
- Cerenovus
- Clarus
- Dewimed
- Elekta
- Embolx
- FHC
- Flowonix
- InoMed
- Integra LifeSciences
- IntraPace
- IRRAS
- Karl Storz
- LivaNova
- Medtronic
- MicroVention
- Misonix
- Mizuho America
- MRC
- NeuroPace
- Nevro
- NICO
- Nuvectra
- Penumbra
- Peter Lazic
- SAI Infusion Technologies
- Saluda
- Scientia Vascular
- Soring
- Sophysa
- Spartan Micro
- Spiegelberg
- Stimwave
- Stryker
- Vascular Solutions
- Visionsense